Results 131 to 140 of about 15,339 (215)
Short daily home hemodialysis (HDD) with low dialysate flow rate has been shown in recent years as an attractive alternative for portable dialysis home use.
M. Moya +11 more
semanticscholar +1 more source
Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients—A Randomized Controlled Clinical Trial [PDF]
Background To increase the removal of middle-sized uremic toxins a new membrane with enhanced permeability and selectivity, called Medium Cut-Off membrane (MCO-Ci) has been developed that at the same time ensures the retention of albumin.
Boehler, Torsten [u.a.] +7 more
core +1 more source
Protein-Bound Uremic Toxins Binding to Human Serum Albumin
Kidney failure is a global health concern, exacerbated by the accumulation of uremic metabolites that persist despite conventional treatments such as hemodialysis (HD). A significant subset of these metabolites, termed protein-bound uremic toxins (PBUTs), bind tightly to human serum albumin (HSA), limiting their removal through traditional separation ...
openaire +1 more source
Effect of Oral N-acetylcysteine Treatment on Immune System in Continuous Ambulatory Peritoneal Dialysis Patients [PDF]
Tujuan: mengevaluasi efek N-asetilsistein (NAS) oral terhadap kadar petanda inflamasi pada pasien Continuous Ambulatory Peritoneal Dialysis (CAPD).
Prasetyo, Diding H., Purwanto, Bambang
core +1 more source
Development of hybrid kidney for removal of protein-bound anionic uremic toxins [PDF]
課題番号 ...
Tsuruoka Shuichi, 鶴岡 秀一
core
Narrative Review of Incremental Hemodialysis. [PDF]
The prescription of hemodialysis (HD) in patients with incident end-stage kidney disease (ESKD) is fundamentally empirical. The abrupt transition from nondialysis chronic kidney disease (CKD) to thrice-weekly in-center HD of much the same dialysis ...
Garneata, Liliana +3 more
core
People with end‐stage chronic kidney disease (CKD) require routine dialysis treatments to remove uremic toxins from the blood in order to minimize toxic symptoms.
Fátima Guerrero +4 more
doaj +1 more source
Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. [PDF]
The aryl hydrocarbon receptor (AhR) is a well-known ligand-activated cytoplasmic transcription factor that contributes to cellular responses against environmental toxins and carcinogens.
Chen, Lin +8 more
core +1 more source
The influence of uremic toxins on low bone turnover disease in chronic kidney disease
Uremic toxins play a crucial role in the development of low bone turnover disease in chronic kidney disease (CKD) through the induction of oxidative stress.
Giou-Teng Yiang +6 more
doaj +1 more source
Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD
INTRODUCTION: Furosemide is commonly prescribed to patients with chronic kidney disease (CKD) but may impair the kidney’s excretion of protein-bound uremic toxins (PBUTs) via the organic anion transporters 1 and 3 (OAT1 and OAT3). We evaluated the association between furosemide prescription (status and dose level) and the serum concentrations of free ...
Margaux Costes-Albrespic +29 more
openaire +2 more sources

